202 related articles for article (PubMed ID: 19890796)
1. 10-Parameter flow cytometry as a new tool to improve diagnosis and MRD follow-up of acute leukemias.
Wehner S; Soerensen J; Schwabe D; Tramsen L; Quaritsch R; Esser R; Klingebiel T; Koehl U
Klin Padiatr; 2009; 221(6):393-5. PubMed ID: 19890796
[No Abstract] [Full Text] [Related]
2. [Acute leukemia in childhood. Classification--diagnosis--therapy--prognosis].
Creutzig U; Schrappe M
Internist (Berl); 1996 Oct; 37(10):982-93. PubMed ID: 9019456
[No Abstract] [Full Text] [Related]
3. [Acute leukemia in childhood].
Fink FM; Gadner H
Wien Med Wochenschr; 1991; 141(9-10):190-5. PubMed ID: 1949840
[TBL] [Abstract][Full Text] [Related]
4. Modern diagnostics in acute leukemias.
Haferlach T; Kern W; Schnittger S; Schoch C
Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
[TBL] [Abstract][Full Text] [Related]
5. The childhood leukemias.
Colby-Graham MF; Chordas C
J Pediatr Nurs; 2003 Apr; 18(2):87-95. PubMed ID: 12720205
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of response to intensive chemotherapy in acute leukaemic patients.
Mód A; Tamáska J; Poros A; Király A; Adám E; Gidáli J; Hollán SR
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():24. PubMed ID: 2627605
[No Abstract] [Full Text] [Related]
7. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of acute leukemia in adults].
Lechner K
Wien Med Wochenschr; 1991; 141(9-10):180-90. PubMed ID: 1949839
[TBL] [Abstract][Full Text] [Related]
9. [Acute leukemias at the Complejo Hospitalario Metropolitano Dr. Arnulfo Arias M. from 1982 to 1990].
Yunsán de Abood M; Arosemena R
Rev Med Panama; 1993 May; 18(2):151-4. PubMed ID: 8327746
[TBL] [Abstract][Full Text] [Related]
10. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.
Al-Mawali A; Gillis D; Lewis I
Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561
[TBL] [Abstract][Full Text] [Related]
11. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
12. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
Campana D; Coustan-Smith E
Best Pract Res Clin Haematol; 2002 Mar; 15(1):1-19. PubMed ID: 11987913
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
14. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
Chen JS; Hsiao CC; Sheen JM; Cheng CN
Leuk Res; 2007 Oct; 31(10):1351-7. PubMed ID: 17445885
[TBL] [Abstract][Full Text] [Related]
15. [The successive presence of acute lymphoblastic leukemia, Hodgkin's disease and acute myeloblastic leukemia in a female patient].
del Potro E; Espinola Guedes G; Martínez R; Alvarez A; Díaz Mediavilla J; Martín C; Villegas A; Espinós D
Rev Clin Esp; 1991 Jun; 189(1):21-2. PubMed ID: 1924921
[TBL] [Abstract][Full Text] [Related]
16. Leukemias of indeterminant lineage.
Lee EJ; Schiffer CA
Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy during pregnancy. Study of the late effects in long-term survivors].
Avilés A
Bol Med Hosp Infant Mex; 1988 Dec; 45(12):803-7. PubMed ID: 3240343
[No Abstract] [Full Text] [Related]
18. Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
Ryan J; Quinn F; Meunier A; Boublikova L; Crampe M; Tewari P; O'Marcaigh A; Stallings R; Neat M; O'Meara A; Breatnach F; McCann S; Browne P; Smith O; Lawler M
Br J Haematol; 2009 Jan; 144(1):107-15. PubMed ID: 19016726
[TBL] [Abstract][Full Text] [Related]
19. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
20. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
